News
Key points When drugs interact it can impact the effectiveness and side effects of either drug. The anti-HIV drugs ritonavir and cobicistat have the most interactions. Discussing recreational drugs ...
Monthly oral PrEP pill advances to phase III trials Professor Kenneth Mayer at IAS 2025. ©Jacques Nkinzingabo/IAS. CC BY-SA 4.0. A once-monthly oral HIV prevention pill has shown promising results in ...
New data presented at the 13th International AIDS Society Conference on HIV Science (IAS 2025) yesterday show that two long-acting injectable PrEP options, lenacapavir and cabotegravir, are safe, well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results